BAM15 vs 2,4-dinitrophenol (DNP)
BAM15 (C-tier) vs 2,4-dinitrophenol (DNP) (F-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.
BAM15 — tier C
a preclinical mitochondrial protonophore that reduced fat gain and improved metabolic measures in mice, with no human exposure, dose-finding, or safety study.
BAM15 has a coherent mechanism and credible mouse metabolic data, but no human bridge and no basis for calling a research-chemical exposure safe.
0 human exposure studies · half-life 1.7 hours in mouse plasma after 10 mg/kg oral gavage; no human half-life · weight loss
2,4-dinitrophenol (DNP) — tier F
a historically effective weight-loss poison that uncouples mitochondrial energy production, can drive uncontrollable hyperthermia and cardiovascular collapse, and has no established antidote.
DNP can reduce weight, and that efficacy is exactly why the safety verdict must be unambiguous: the mechanism has killed people and offers no controllable clinical margin for this use.
F site tier because effective weight loss does not justify lethal uncoupling risk · half-life not structured; poisoned-patient estimates and animal two-compartment disposition are not a normal-use human PK value · weight loss
at a glance
- BAM15: tier C · 0 human exposure studies
- 2,4-dinitrophenol (DNP): tier F · F site tier because effective weight loss does not justify lethal uncoupling risk
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.
